Props to RTB on this one...upon his reply, I took
Post# of 148179
Fife looks to have received 26.5mm shares since Jan 15th to settle the balances of the July & Nov 2020 notes ($900k left in Nov, small amount). This also jives with the shares outstanding increase from 598 to 634 during that time.
As of 1/14/21 he owned 5.1mm shares per the S-3
As of 8/18/21 he owned 7.75mm shares per the S-3
Add in the 26.5mm shares received and that it implies he sold ~24mm shares from 1/14 thru 8/18. That's ~5% of the ~518mm shares that traded during that timeframe (not a large number but worth the mention).
And RTB was correct, the 5.7mm wasn't received by Fife a few days ago, but simply registered in this recent S-3. It is tied to the $10 conversion price, aka potentially $57mm worth of stock which aligns with the $57mm of remaining debt obligation to Fife (the 2 April notes).
Overall still not a needle mover in the grand scheme of my personal investment thesis here (i.e. approval, EUA, partnership, milestone payments, revs in the next 6-12 months can quickly wipe the slate entirely clean with pure upside from there - multiple catalysts in the next few months as well, etc.).
However, to maintain the integrity of my posts, this board, and give credit where credit is due (RTB), I wanted to correct my earlier post.
Debt is necessary to attain lofty goals, it's no different here. If Fife is our bridge loan to billions, I'm ok with that. It's like paying premium to continuously roll a call option where the payout is 100's of times the risk. Need to step back and look at the forest for the trees when you are an investor - LL is a miracle drug, it won't be kept out of market forever, it simply is THAT good. Literally a life saving drug. Fact.
Super excited for the next few months to play out. Cdiddy will start posting as Cgiddy once again!
Lord Nader vs. the drug industry:
https://www.youtube.com/watch?v=SFO4kUdX7q4